PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Virology, School of Medicine, Technical University of Munich, 81675, Munich, Germany. martin.feuerherd@tum.de.\', \'Institute of Virology, Helmholtz Zentrum München, Munich, Germany. martin.feuerherd@tum.de.\', \'B. Braun Melsungen AG, Branch Dortmund, Center of Competence Breath Analysis, BioMedicalCenter, Dortmund, Germany.\', \'Department of Internal Medicine II, University Hospital Rechts Der Isar, School of Medicine, Technical University of Munich, Munich, Germany.\', \'Institute of Virology, School of Medicine, Technical University of Munich, 81675, Munich, Germany.\', \'Institute of Virology, Helmholtz Zentrum München, Munich, Germany.\', \'German Center for Infection Research (DZIF), Munich Partner Site, Munich, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41598-021-99742-7
?:doi
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 34635788
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
?:title
  • A proof of concept study for the differentiation of SARS-CoV-2, hCoV-NL63, and IAV-H1N1 in vitro cultures using ion mobility spectrometry.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all